These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 35335131)
1. A Sub-Micromolar MraY Oliver M; Le Corre L; Poinsot M; Bosco M; Wan H; Amoroso A; Joris B; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C Molecules; 2022 Mar; 27(6):. PubMed ID: 35335131 [TBL] [Abstract][Full Text] [Related]
2. New MraY Wan H; Ben Othman R; Le Corre L; Poinsot M; Oliver M; Amoroso A; Joris B; Touzé T; Auger R; Calvet-Vitale S; Bosco M; Gravier-Pelletier C Antibiotics (Basel); 2022 Sep; 11(9):. PubMed ID: 36139968 [TBL] [Abstract][Full Text] [Related]
3. 5'-Methylene-triazole-substituted-aminoribosyl uridines as MraY inhibitors: synthesis, biological evaluation and molecular modeling. Fer MJ; Bouhss A; Patrão M; Le Corre L; Pietrancosta N; Amoroso A; Joris B; Mengin-Lecreulx D; Calvet-Vitale S; Gravier-Pelletier C Org Biomol Chem; 2015 Jul; 13(26):7193-222. PubMed ID: 26008868 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and molecular modeling of urea-containing MraY inhibitors. Oliver M; Le Corre L; Poinsot M; Corio A; Madegard L; Bosco M; Amoroso A; Joris B; Auger R; Touzé T; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C Org Biomol Chem; 2021 Jul; 19(26):5844-5866. PubMed ID: 34115086 [TBL] [Abstract][Full Text] [Related]
5. Structural insights into inhibition of lipid I production in bacterial cell wall synthesis. Chung BC; Mashalidis EH; Tanino T; Kim M; Matsuda A; Hong J; Ichikawa S; Lee SY Nature; 2016 May; 533(7604):557-560. PubMed ID: 27088606 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY. Kwak SH; Lim WY; Hao A; Mashalidis EH; Kwon DY; Jeong P; Kim MJ; Lee SY; Hong J Eur J Med Chem; 2021 Apr; 215():113272. PubMed ID: 33607457 [TBL] [Abstract][Full Text] [Related]
10. Toward analogues of MraY natural inhibitors: synthesis of 5'-triazole-substituted-aminoribosyl uridines through a Cu-catalyzed azide-alkyne cycloaddition. Fer MJ; Olatunji S; Bouhss A; Calvet-Vitale S; Gravier-Pelletier C J Org Chem; 2013 Oct; 78(20):10088-105. PubMed ID: 24044436 [TBL] [Abstract][Full Text] [Related]
11. Structural basis for selective inhibition of antibacterial target MraY, a membrane-bound enzyme involved in peptidoglycan synthesis. Hering J; Dunevall E; Ek M; Brändén G Drug Discov Today; 2018 Jul; 23(7):1426-1435. PubMed ID: 29778697 [TBL] [Abstract][Full Text] [Related]
12. [Bridge between Total Synthesis of Bioactive Natural Products and Development of Drug Leads]. Ichikawa S Yakugaku Zasshi; 2022; 142(4):355-363. PubMed ID: 35370192 [TBL] [Abstract][Full Text] [Related]
13. Insights into the Target Interaction of Naturally Occurring Muraymycin Nucleoside Antibiotics. Koppermann S; Cui Z; Fischer PD; Wang X; Ludwig J; Thorson JS; Van Lanen SG; Ducho C ChemMedChem; 2018 Apr; 13(8):779-784. PubMed ID: 29438582 [TBL] [Abstract][Full Text] [Related]
14. Chemical logic of MraY inhibition by antibacterial nucleoside natural products. Mashalidis EH; Kaeser B; Terasawa Y; Katsuyama A; Kwon DY; Lee K; Hong J; Ichikawa S; Lee SY Nat Commun; 2019 Jul; 10(1):2917. PubMed ID: 31266949 [TBL] [Abstract][Full Text] [Related]
15. Exploring the Active Site of the Antibacterial Target MraY by Modified Tunicamycins. Hering J; Dunevall E; Snijder A; Eriksson PO; Jackson MA; Hartman TM; Ting R; Chen H; Price NPJ; Brändén G; Ek M ACS Chem Biol; 2020 Nov; 15(11):2885-2895. PubMed ID: 33164499 [TBL] [Abstract][Full Text] [Related]
16. Structures of Bacterial MraY and Human GPT Provide Insights into Rational Antibiotic Design. Mashalidis EH; Lee SY J Mol Biol; 2020 Aug; 432(18):4946-4963. PubMed ID: 32199982 [TBL] [Abstract][Full Text] [Related]
17. GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation. Yoo J; Mashalidis EH; Kuk ACY; Yamamoto K; Kaeser B; Ichikawa S; Lee SY Nat Struct Mol Biol; 2018 Mar; 25(3):217-224. PubMed ID: 29459785 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of the nucleoside moiety of liposidomycins: elucidation of the pharmacophore of this family of MraY inhibitors. Dini C; Collette P; Drochon N; Guillot JC; Lemoine G; Mauvais P; Aszodi J Bioorg Med Chem Lett; 2000 Aug; 10(16):1839-43. PubMed ID: 10969981 [TBL] [Abstract][Full Text] [Related]
19. Theoretical investigation of the effects of diverse hydrogen-bonding characteristics on the Astani EK; Iravani H; Sardari S Solid State Nucl Magn Reson; 2024 Oct; 133():101960. PubMed ID: 39208660 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and conformation-activity relationship analysis of LNA/BNA-type 5'-O-aminoribosyluridine as MraY inhibitors. Kusaka S; Yamamoto K; Shinohara M; Minato Y; Ichikawa S Bioorg Med Chem; 2022 Jul; 65():116744. PubMed ID: 35500521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]